Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

501
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
501
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CHAIN Cohort: Prospective Multicenter Study of MASLD With Serial Liver Stiffness Assessments in Cardiovascular Care.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

BioRENLI: enhancing large language models for biomedical relation extraction through preference-aligned natural language inference.

Health information science and systems·2026
Same author

Investigating association of triglycerides with hemodynamic parameters in patients with Low cardiovascular risk using 4D flow MRI.

Frontiers in cardiovascular medicine·2026
Same author

Gnao1 acts as a gatekeeper to alleviate neuropathic pain by silencing pro-nociceptive signaling cascades.

The journal of headache and pain·2026
Same author

Havruta-structured dialogue as a social-emotional competence intervention: multi-stakeholder evidence on university students' mental health.

Frontiers in psychology·2026
Same author

A simple LC-MS/MS method for the simultaneous determination of 18 free fatty acids in human serum.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026

Related Experiment Video

Updated: Jun 3, 2025

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

67.9K

Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression.

Long Teng1, Ling Luo1, Yanhong Sun2

  • 1Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.

Nutrients
|January 11, 2025
PubMed
Summary

Monitoring 1-hour post-glucose (1hPG) levels is crucial for identifying metabolic dysfunction-associated steatotic liver disease (MASLD) and associated complications like liver injury and atherosclerosis. This highlights the importance of 1hPG in clinical screening and management.

Keywords:
alanine aminotransferaseatherosclerotic cardiovascular diseaseclinical outcomesliver fibrosisliver steatosismetabolic dysfunction-associated steatotic liver diseaseoral glucose tolerance testpost-load glucose

More Related Videos

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

5.2K
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

10.9K

Related Experiment Videos

Last Updated: Jun 3, 2025

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

67.9K
Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

5.2K
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

10.9K

Area of Science:

  • Metabolic Syndrome
  • Hepatology
  • Cardiovascular Disease

Background:

  • The 1-hour post-load plasma glucose (1hPG) test is proposed as an alternative diagnostic criterion for prediabetes/diabetes.
  • Its efficacy in identifying progressive metabolic dysfunction-associated steatotic liver disease (MASLD) requires further investigation.

Purpose of the Study:

  • To evaluate the superiority of 1hPG compared to 2-hour post-glucose (2hPG) in identifying MASLD.
  • To assess the association of 1hPG and 2hPG with liver steatosis, fibrosis, injury, and atherosclerosis in Asian participants.

Main Methods:

  • Retrospective enrollment of 2214 Asian participants (1049 non-MASLD, 1165 MASLD) between June 2012 and June 2024.
  • Liver steatosis quantified by CT scan; liver fibrosis assessed using serum markers.
  • Statistical analysis included odds ratios (OR) and receiver operating characteristic (ROC) curve analysis.

Main Results:

  • Elevated 1hPG levels were significantly associated with moderate to severe liver steatosis in MASLD patients (OR=2.19).
  • Both elevated 1hPG and 2hPG were linked to increased risk of liver injury (OR=2.03) and atherosclerosis (OR=2.77 for 1hPG, OR=2.98 for 2hPG).
  • Elevated 2hPG levels were associated with liver fibrosis (OR=1.99-2.72).

Conclusions:

  • The study emphasizes the clinical necessity of monitoring 1hPG levels for screening and managing MASLD.
  • 1hPG demonstrates utility in identifying MASLD and associated metabolic complications, including liver injury and atherosclerosis.
  • These findings support the integration of 1hPG monitoring into clinical practice for MASLD patients.